TIL Valuation

Instil Bio Inc

Add to Watchlist

Advanced Chart

27.840

-0.405(-1.434%)1D

Overview
Forecast
Valuation
Earnings

TIL Relative Valuation

TIL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TIL is overvalued; if below, it's undervalued.

Historical Valuation

Instil Bio Inc (TIL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.38. The fair price of Instil Bio Inc (TIL) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：27.84

Fair

-2.72

Trailing

Forward

0.00

EV/EBITDA

Instil Bio Inc. (TIL) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -3.23. The thresholds are as follows: Strongly Undervalued below -14.41, Undervalued between -14.41 and -8.82, Fairly Valued between 2.36 and -8.82, Overvalued between 2.36 and 7.95, and Strongly Overvalued above 7.95. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-2.25

EV/EBIT

Instil Bio Inc. (TIL) has a current EV/EBIT of -2.25. The 5-year average EV/EBIT is -2.91. The thresholds are as follows: Strongly Undervalued below -12.88, Undervalued between -12.88 and -7.89, Fairly Valued between 2.07 and -7.89, Overvalued between 2.07 and 7.05, and Strongly Overvalued above 7.05. The current Forward EV/EBIT of -2.25 falls within the Historic Trend Line -Fairly Valued range.

0.00

Instil Bio Inc. (TIL) has a current PS of 0.00. The 5-year average PS is 2987.29. The thresholds are as follows: Strongly Undervalued below -17222.31, Undervalued between -17222.31 and -7117.51, Fairly Valued between 13092.09 and -7117.51, Overvalued between 13092.09 and 23196.90, and Strongly Overvalued above 23196.90. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Instil Bio Inc. (TIL) has a current P/OCF of 0.00. The 5-year average P/OCF is -6.24. The thresholds are as follows: Strongly Undervalued below -25.28, Undervalued between -25.28 and -15.76, Fairly Valued between 3.29 and -15.76, Overvalued between 3.29 and 12.81, and Strongly Overvalued above 12.81. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-3.98

P/FCF

Instil Bio Inc. (TIL) has a current P/FCF of -3.98. The 5-year average P/FCF is -4.03. The thresholds are as follows: Strongly Undervalued below -14.86, Undervalued between -14.86 and -9.45, Fairly Valued between 1.39 and -9.45, Overvalued between 1.39 and 6.81, and Strongly Overvalued above 6.81. The current Forward P/FCF of -3.98 falls within the Historic Trend Line -Fairly Valued range.

Instil Bio Inc (TIL) has a current Price-to-Book (P/B) ratio of 1.28. Compared to its 3-year average P/B ratio of 0.54 , the current P/B ratio is approximately 138.31% higher. Relative to its 5-year average P/B ratio of 1.34, the current P/B ratio is about -4.32% higher. Instil Bio Inc (TIL) has a Forward Free Cash Flow (FCF) yield of approximately -24.47%. Compared to its 3-year average FCF yield of -167.61%, the current FCF yield is approximately -85.40% lower. Relative to its 5-year average FCF yield of -111.84% , the current FCF yield is about -78.13% lower.

1.28

P/B

Median3y

0.54

Median5y

1.34

-24.47

FCF Yield

Median3y

-167.61

Median5y

-111.84

Competitors Valuation Multiple

The average P/S ratio for TIL's competitors is 5.85, providing a benchmark for relative valuation. Instil Bio Inc Corp (TIL) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Tevogen Bio Holdings Inc

Loss

186.54M

CRBU.O

Caribou Biosciences Inc

Crescent Biopharma Inc

Loss

191.58M

TRDA.O

Entrada Therapeutics Inc

16.16

-97.94%

200.46M

Performance Decomposition

Market capitalization of TIL increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of TIL in the past 1 year is driven by Unknown.